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Abstract. In type 2 diabetes mellitus, there are changes in hemostasis components, including 
overexpression of PAI-1. By these facts, the authors are interested in conducting the study of 
PAI-1 level in diabetic patients with and without foot ulcer. Methods: The sample of this 
research was collected cross-sectionally on 20 type 2 diabetic patients with foot ulcer and 20 
without foot ulcer. Blood samples were taken to measure serum PAI-1 level, complete blood 
count and hemostasis screening test. Results: Statistical analysis showed there are significant 
differences in hemoglobin, trombosit, Fibrinogen and D-dimer levels in the ulcer and non-
ulcer groups but no significant difference in PAI-1 level. Conclusions: No higher PAI – 1 
level were found in diabetic foot ulcer group than those without diabetic foot ulcer. There 
was no significant difference between PAI-1 level and grade of diabetic foot ulcer. 
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Abstrak. Pada diabetes mellitus tipe 2, ada perubahan dalam komponen hemostasis, 
termasuk overekspresi PAI-1. Dengan fakta-fakta ini, penulis tertarik untuk melakukan 
penelitian tingkat PAI-1 pada pasien diabetes dengan dan tanpa ulkus kaki. Metode: Sampel 
penelitian ini dikumpulkan secara cross-sectional pada 20 pasien diabetes tipe 2 dengan 
ulkus kaki dan 20 tanpa ulkus kaki. Sampel darah diambil untuk mengukur kadar serum PAI-
1, hitung darah lengkap dan tes skrining hemostasis. Hasil: Analisis statistik menunjukkan 
ada perbedaan yang signifikan dalam kadar hemoglobin, trombosit, Fibrinogen dan D-dimer 
pada kelompok ulkus dan non-ulkus tetapi tidak ada perbedaan yang signifikan dalam 
tingkat PAI-1. Kesimpulan: Tidak ada tingkat PAI - 1 yang lebih tinggi ditemukan pada 
kelompok ulkus kaki diabetik dibandingkan dengan mereka tanpa ulkus kaki diabetik. Tidak 
ada perbedaan yang signifikan antara tingkat PAI-1 dan tingkat ulkus kaki diabetik.    
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1. Introduction 
Nowadays, researches and data about changes in PAI-1 level in type 2 diabetic patients are still 
limited to type 2 diabetes mellitus and diabetic foot. By this reason, we are interested to conduct 
a research of PAI-1 level in type 2 diabetic patients, with and without diabetic foot ulcer. The 
special purpose of this research is to compare the level of Plasminogen Activator Inhibitor-1 in 
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type 2 diabetic patients with and without diabetic foot ulcer and the main purpose is to 
differentiate coagulation status of type 2 diabetic patients with and without diabetic foot ulcer. 
2. Methodology 
This is a cross sectional descriptive analytic study which was conducted at May-July 2017 in 
RSUP H Adam Malik Medan on 20 hospitalized type 2 diabetic patients with diabetic foot 
according to Wagner criteria and 20 hospitalized type 2 diabetic patients without diabetic foot. 
All of them fulfills inclusion and exclusion criteria and blood samples were withdrawn for PAI-1 
serum level, complete blood count and hemostasis screening test. 
This research data will be analyzed by using SPSS (Statistical Product and Science Service) for 
Windows. 
3. Results 
In this study, the subjects are diabetic patients with and without diabetic foot ulcer, 20 patients 
each. The results of this research are explained by the following tables. 
Table 1 does not show significant differences between the two groups of age and gender (p > 
0.05). But for laboratory results, by statistic means, it shows significant differences of 
hemoglobin, platelet, Fibrinogen and D-dimer between diabetic foot ulcer and non-ulcer groups 
(p < 0.05). Grade 4 and grade 3 were in the top lists by 50% and 35%. The least was grade 5 
(15%). This study obtains coagulation state of 20 diabetic patients with diabetic foot ulcer 14 
patients (70%) with hypercoagulative and 6 patients (30%) with hypocoagulative respectively. 
 
Table 1. Study Subjects Characteristics 
Characteristics Study Subjects  
 Diabetic Foot Ulcer 
(n=20) 
Mean ± SD 
Without Diabetic Foot 
Ulcer  
(n=20) 
Mean ± SD 
P Value 
 
Age (Years) 
40-49 
50-59 
60-69 
 
5 (25%) 
11(55%) 
4  (20%) 
 
3 (15%) 
10 (50%) 
7(35%) 
 
 
0,493a 
 
Gender 
Man 
Woman 
 
13 (65%) 
7 (35%) 
 
10 (50%) 
10 (50%) 
 
0,337b 
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Ulcer Grade 
0 
3 
4 
5 
 
0 
7 (35%) 
10 (50%) 
3 (15%) 
 
20 (100%) 
0 
0 
0 
 
Complete Blood Count    
Hb (g/dL) 10.7 ± 1.7 13,1 ±1,7 0,001d 
Trombosit( x 103/mm3) 381 ± 122 303 ± 110 0,041d 
Fibrinogen(mg/dL) 445 ± 215 291 ± 90 0,009c 
D-Dimer(ng/mL) 648 ± 313 404 ± 302 0,017d 
Coagulation State 
Hypercoagulative  
 
14 (70%) 
  
                           aFisher exact test        bChi-square test         cMann-Whitney test      d T-test 
Table 2 shows PAI-1 level in diabetic foot ulcer patients is in median 14,06 ng/mL lower than 
without ulcer PAI-1 group (16.71 ng/mL). Mann-Whitney Test shows no significant difference 
of PAI-1 level between diabetic foot ulcer and without ulcer groups (p > 0.05). PAI-1 level in 
diabetic foot ulcer patients is in median 12,51 ng/mL with hypercoagulative and 20,59 ng/mL 
with hypocoagulative. Mann-Whitney Test shows no significant difference of PAI-1 level in 
diabetic foot ulcer with hypercoagulative and hypocoagulative groups (p > 0.05). 
Table 2. Differences of Pai Level (Ng/Ml) in Type 2 Diabetes Mellitus with and without 
Diabetic Foot Ulcer and Correlation of Coagulation State and Pai-1 Level 
  With 
Ulcer 
n = 20 
Without 
Ulcer 
n = 20 
  P 
Hypercoagulative 
With Ulcer 
n = 14 
Hypocoagulative 
With Ulcer 
n = 6 
          
P 
PAI – 1 
(ng/mL) 
 
 
 
14,06  
(7,25 - 
138,71) 
 
16,71  
(2,62 - 
63,47) 
0,957 
12,51 
(7,25 – 120,01) 
20,59 
(2,62 – 138,71) 
0,509 
 
 
Table 3 shows no significant correlation between the grading of diabetic foot ulcer and PAI-1 
level. (r=0.16; p=0.505). 
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Table 3. Correlation Of Diabetic Foot Ulcer Grades And Pai-1 Level 
 
Grade 3 
(n=7) 
Grade 4 
(n=10) 
Grade 5 
(n=3) 
P r 
 
PAI-1 (ng/mL) 
12,48 
(8,44-20,89) 
35,26 
(7,25-138,71) 
9,05 
(8,50-137,35) 
 
0,505 0,16 
 
4. Discussion 
This study shows PAI-1 level in diabetic foot ulcer patients is in median 14,06 ng/mL lower than 
without ulcer PAI-1 group (16.71 ng/mL). Mann-Whitney Test shows no significant difference 
of PAI-1 level between diabetic foot ulcer and without ulcer groups (p > 0.05). Schneider and 
Sobel in 2012 found that PAI-1 level is increased in type 2 diabetes mellitus patients [1]. In 
contrast, Kulwas et al in 2016 found that PAI-1 concentration in diabetic foot, type 2 diabetes 
without vascular complication and control group show no significant statistical differences [2]. In 
contrast to a study by Rautio A et al in 2016 in Sweden who found after 10 years observed that 
level of PAI-1 increased statistically significantly in non-diabetic and type 1 diabetes melitus 
subjects, in contrast to type 2 diabetes melitus which decreased PAI-1 level statistically significant 
in type 2 diabetes mellitus [3]. 
The result of this study shows no significant correlation between grade of diabetic foot ulcer and 
PAI-1 level, which agrees with Kulwas et al study that shows no significant differences between 
PAI-1 concentration and various of diabetic foot grading by Wagner’s criteria [2]. 
As stated above, diabetes mellitus is involed in prothrombotic condition [4]. Increasing PAI-1 
level in diabetes patient is believed to be multifactorial. The combination of hyperinsulinemia, 
hypertriglyceridemia and hyperglycemia increase PAI-1 concentration in the blood. PAI-1 is a 
linear glycoprotein produced by endothelium functioning as primary inhibitor of t-PA and u-PA 
activities on fibrinolysis. Bonding of PAI-1 in the plasma and extracellular matrix is stabilized by 
vitronectin. Only few PAI-1 can be found in the normal fresh plasma compared to fresh blood 
containing platelet, due to vitronectin is contained in platelet which supports PAI-1 as the main 
factor of resistance properties of thrombus containing much platelet will be more resistant to 
thrombolysis process [5].  
The limitations of this study are it is conducted in only one health center, there is no data on how 
long the patient had type 2 diabetes mellitus and does not analyse the length of morbidity and 
whether the diabetes is controlled or not. Previously, Rubeaan et al found that the duration of 
morbidity and HbA1c is significantly higher in diabetic foot ulcer, gangrene and amputation 
compared to nonaffected patients [6]. Besides, there is no inflammatory marker data that can be 
used as predictors of severity of diabetic foot ulcers. And there is no examination of other factors 
that may affect coagulation, such as albumin. 
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In conclusion, no higher PAI-1 level were found in diabetic foot ulcer group than those without 
diabetic foot ulcer. There was no significant difference between PAI-1 level and grade of diabetic 
foot ulcer. 
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